期刊文献+

COX-2抑制剂对人红白血病HEL细胞增殖、凋亡及迁移的影响 被引量:2

Effects of COX-2 inhibitor on proliferation, apoptosis and migration of human erythroleukemia HEL cells
下载PDF
导出
摘要 目的 :探讨环氧化酶(cyclooxygenase-2,COX-2)抑制剂塞来昔布对人红白血病HEL细胞增殖、凋亡及迁移的影响及其作用机制。方法:不同浓度的塞来昔布处理HEL细胞,CCK-8法检测细胞增殖抑制率;Hoechst33342荧光染色检测细胞凋亡;Transwell小室检测细胞迁移率;RT-PCR检测COX-2及JAK2 mRNA水平;Western blot检测COX-2及p-JAK2蛋白表达。结果:塞来昔布能够时间和剂量依赖性抑制HEL细胞增殖,不同浓度(25、75、125μmol/L)的塞来昔布在48 h时对细胞生长抑制率分别为(9.96±0.82)%、(18.46±2.01)%、(21.36±2.48)%(P<0.05);Hoechst33342凋亡细胞染色显示125μmol/L塞来昔布处理HEL细胞后,凋亡细胞明显增多;细胞迁移实验结果显示75μmol/L塞来昔布处理细胞24 h后漏出细胞为(22.13±7.51)个,明显低于对照组(77.89±6.94)个,P<0.05;RT-PCR结果显示不同浓度塞来昔布处理HEL细胞48 h后COX-2 mRNA呈剂量依赖性减低,而对JAK2 m RNA无明显影响;Western blot结果显示塞来昔布处理HEL细胞COX-2蛋白表达明显减低(P<0.05),而对p-JAK2无明显影响。结论:塞来昔布能够抑制HEL细胞增殖,可能与抑制COX-2表达有关,而对JAK2信号通路无明显影响。 Objective:To investigate COX-2 inhibitor effect of celecoxib on proliferation, apoptosis and migration of human erythroleukemia HEL cells and its mechanism. Methods: The human erythroleukemia HEL cells were treated with different concentrations of celecoxib. The cell proliferation inhibition rate was calculated by CCK-8 test; the apoptosis rate was detected by Hoechst33342 fluorescent staining; cell migration ability was tested by transwell chambers. The expression levels of COX-2 and JAK2 m RNA were detected by Real-time PCR; the protein expression levels of COX2 and p-JAK2 were detected by Western blotting assay.Results: Celecoxib time and dose dependently inhibited the proliferation of HEL cells, the cell growth inhibition rates were(9.96 ± 0.82)%,(18.46 ± 2.01)% and(21.36 ± 2.48)%, respectively(P〈0.05), after treated with different concentrations(25,75,and 125 μmol / L,respectively) of celecoxib in HEL cells after 48 h. Hoechst33342 fluorescent staining showed that apoptosis increased significantly after treatment of 125 μmol / L celecoxib in HEL cells after 48 h; cell migration ability showed that the leakage after treated with75 μmol / L celecoxib in HEL cells after 24 h was 22.13 ± 7.51, which was significantly lower than that of the control group(77.89 ±6.94, P〈0.05); RT-PCR results showed that COX-2 m RNA was dependently decreased, while no significant effect on the JAK2 m RNA after treated with different concentrations of celecoxib; Western blotting assay showed that the expression of COX-2 protein in the experimental group was significantly lower than that in the control group(P〈0.05), but no obvious effect was found on p-JAK2 expression. Conclusion: Proliferation of HEL cells can be inhibited by celecoxib. It may be related to the inhibition of the expression of COX-2, but had no obvious effect on JAK2 signaling pathway.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第4期435-439,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 河北省重点研发科技项目(162777120D) 保定市科学技术研究与发展指导计划(12ZF105)
关键词 塞来昔布 HEL细胞系 COX-2 JAK2 celecoxib human erythroleukemia cell line COX-2 JAK2
  • 相关文献

参考文献13

  • 1Song G,Li Y,Jiang G. Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Re- view)[J]. Oneol Rep,2012,28(6) : 1935-1944.
  • 2付建珠,徐倩,赵亚玲,刘贵敏,成志勇,梁文同,谢旭磊,谷蕾.干扰素抑制JAK2V617F阳性骨髓增殖性肿瘤血管新生的机制[J].中华医学杂志,2015,95(46):3727-3732. 被引量:19
  • 3Vural F,Soyer N,Hekimgil M,et al. The association be- tween COX-2 expression and survival in myeloma patients [J]. Eur Rev Med Pharmacol Sci,2014, 18 (15):2132- 2136.
  • 4Sobolewski C,Muller F,Cerella C,et al. Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model [ J ]. Mol Carcinog, 2015,54 (10) : 999-1013.
  • 5成志勇,李士辉,杨琳,黄月华,潘崚.干扰素α对JAK2V617阳性的骨髓增殖性疾病的影响[J].实用肿瘤杂志,2008,23(4):318-321. 被引量:11
  • 6Valverde A,Pefiarando J,Cafias A,et al. Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 tar- gets sternness-related pathways in colorectal cancer cells [J]. PLoS One,2015,10(6):e0131363.
  • 7Cahlin C,Ltinnroth C,Arvidsson A,et al. Growth associated proteins in tumor cells and stroma related to disease pro- gression of colon cancer accounting for tumor tissue PGE2 content[J]. Int J 0ncol,2008,32(4) :909-918.
  • 8Ahorki NK,Keresztes RS,Port JL,et al. Celecoxib,a se- lective eyelonxygenase-2 inhibitor,enhances the response to preoperative paclitaxel andcarboplatin in early-stage non-small-cell lung cancer [J]. J Clin Oncol,2003,21 (14):2645-2650.
  • 9胥昀,赵妍敏,黄河,曾芬芳,周倩.塞来昔布诱导急性早幼粒细胞白血病细胞株MR2凋亡及机制的研究[J].浙江大学学报(医学版),2007,36(4):319-324. 被引量:3
  • 10Waskewih C,Blumenthal RD,Li HL,et al. Celecoxib ex- hibits the greatest potency amongst cyclooxygenase and epithelial cell lines [ J ]. Cancer Res, 2002,62 (7) : 2029- 2033.

二级参考文献26

共引文献43

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部